Silarx Pharmaceuticals, Inc. | Lannett Co. | New York | state | 2015 | $952,757 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | $952,634 | | tax credit/rebate |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2012 | $952,032 | | tax credit/rebate; property tax abatement |
SmithKline Beecham Corporation DBA GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | 2011 | $951,581 | | tax credit/rebate |
Regeneron 1CSC Office/Lab Extension | Regeneron Pharmaceuticals | New York | local | 2020 | $951,284 | | tax credit/rebate |
EMD Millipore Corporation | Merck KGaA (EMD) | California | state | 2018 | $945,000 | | tax credit/rebate |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2001 | $944,526 | | enterprise zone |
Pfizer Inc & Subsidiaries | Pfizer | Iowa | state | 2010 | $942,184 | | tax credit/rebate |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2003 | $939,077 | | enterprise zone |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2016 | $938,710 | | tax credit/rebate |
Doral/Pfizer | Pfizer | New York | local | 2009 | $932,710 | | tax credit/rebate; property tax abatement |
Dava Pharmaceuticals, Inc. | Endo International | New Jersey | state | 2004 | $931,560 | | grant |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | local | 2014 | $930,000 | | grant |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | Local | 2018 | $920,908 | | tax credit/rebate |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2014 | $914,646 | | tax credit/rebate |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | | enterprise zone |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2019 | $904,695 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $903,866 | | tax credit/rebate |
ImClone Systems LLC | Eli Lilly | New York | state | 2012 | $901,984 | | enterprise zone |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $900,091 | | tax credit/rebate |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2015 | $900,000 | | tax credit/rebate |
Boehringer Ingelheim Fremont Inc | Boehringer Ingelheim | California | state | 2021 | $898,743 | | training reimbursement |
Novozymes Blair, Inc. | Novo Holdings A/S | Nebraska | state | 2018 | $895,622 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2020 | $894,247 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Eli Lilly | North Carolina | state | 2015 | $885,684 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2015 | $881,846 | | tax credit/rebate |
Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals | Massachusetts | state | 2012 | $880,128 | | tax credit/rebate |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2008 | $879,466 | | tax credit/rebate |
RegeneronN | Regeneron Pharmaceuticals | New York | local | 2020 | $878,388 | | tax credit/rebate |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2009 | $877,386 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2009 | $877,386 | | enterprise zone |
Merck & Co., Inc. | Merck | New Jersey | state | 1999 | $874,000 | | grant |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2016 | $868,373 | | property tax abatement |
Pfizer, Inc. | Pfizer | New York | local | 2008 | $862,541 | | tax credit/rebate; property tax abatement |
ABBOTT DIABETES CARE | Abbott Laboratories | California | state | 2010 | $843,336 | | training reimbursement |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2002 | $828,938 | | enterprise zone |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2014 | $822,257 | | property tax abatement |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $816,254 | | tax credit/rebate |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 1998 | $815,500 | | tax credit/rebate |
Novartis | Novartis | New Jersey | state | 2005 | $810,000 | | tax credit/rebate |
Aventis Pasteur Inc. | Sanofi | Pennsylvania | state | | $810,000 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2019 | $802,663 | | tax credit/rebate |
Wyeth | Pfizer | Pennsylvania | state | 2008 | $802,021 | | tax credit/rebate |
Cambridge Major Laboratories, Inc. | Alcami | Wisconsin | state | 2014 | $800,000 | | tax credit/rebate |
Amneal (50 Horseblock-NM AMNL) | Amneal Pharmaceuticals | New York | local | 2021 | $795,000 | | tax credit/rebate |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $794,527 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $794,527 | | enterprise zone |
MedImmune LLC | AstraZeneca | Maryland | state | 2021 | $794,270 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2020 | $791,333 | | tax credit/rebate |
Spark Therapeutics, LLC | Roche | Pennsylvania | state | 2017 | $790,740 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2010 | $790,040 | | tax credit/rebate; property tax abatement |
Zoetis, LLC | Zoetis | Nebraska | state | 2022 | $789,317 | | tax rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2020 | $788,701 | | tax credit/rebate |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2013 | $784,000 | | tax credit/rebate |
Ultragenyx Pharmaceutical | Ultragenyx Pharmaceutical | Massachusetts | state | 2020 | $780,952 | | tax credit/rebate |
Amgen Inc. | Amgen | Massachusetts | state | 2016 | $780,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $770,277 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2015 | $765,357 | | tax credit/rebate |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2014 | $764,142 | | enterprise zone |
Pfizer, Inc. | Pfizer | North Carolina | state | 2013 | $755,362 | | tax credit/rebate |
MALLINCKRODT MEDICAL, INC. | Mallinckrodt | Missouri | state | 2000 | $754,909 | | tax credit/rebate |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $751,067 | | tax credit/rebate |
Novartis | Novartis | New Jersey | state | 2005 | $750,000 | | tax credit/rebate |
Endo Pharmaceuticals | Endo International | Pennsylvania | state | | $750,000 | | grant |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $750,000 | | tax credit/rebate |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2009 | $750,000 | | grant |
EMERGENT BIOSOLUTIONS INC | Emergent BioSolutions | Maryland | local | 2014 | $750,000 | | grant/loan hybrid program |
Abiomed Inc | Johnson & Johnson | Massachusetts | state | 2017 | $750,000 | | tax credit/rebate |
Abiomed, Inc. | Johnson & Johnson | Massachusetts | state | 2018 | $750,000 | | tax credit/rebate |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2015 | $749,365 | | property tax abatement |
Novo Nordisk Pharmaceuticals | Novo Holdings A/S | North Carolina | state | 2008 | $746,648 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2011 | $743,297 | | tax credit/rebate |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2011 | $740,939 | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2014 | $740,512 | | training reimbursement |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $740,231 | | tax credit/rebate |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $735,000 | | training reimbursement |
GlaxoSmithKline | GlaxoSmithKline | United States | federal | 2012 | $729,692 | | federal grant |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2005 | $728,623 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2017 | $726,780 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2019 | $723,229 | | tax credit/rebate |
Janssen Biotech, Inc. | Johnson & Johnson | Pennsylvania | state | 2017 | $720,954 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2009 | $718,878 | | tax credit/rebate |
Regeneron - 1 CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2015 | $715,196 | | tax credit/rebate |
Aegerion Pharmaceuticals | Amryt Pharma | Massachusetts | state | 2014 | $715,085 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2015 | $709,291 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2015 | $708,343 | | tax credit/rebate |
Doral Arrowwood (Pfizer) | Pfizer | New York | local | 2005 | $701,075 | | tax credit/rebate; property tax abatement |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | | $699,000 | | tax credit/rebate |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Medimmune, LLC | AstraZeneca | Maryland | state | 2010 | $698,034 | | tax credit/rebate |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $695,000 | | grant |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2017 | $693,503 | | tax credit/rebate |
Actavis, Inc. | AbbVie | Florida | state | 2013 | $690,000 | | grant |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2013 | $687,362 | | tax credit/rebate |
Perceptive Services, Inc. | Parexel International | New Jersey | state | 2005 | $685,125 | | grant |